期刊
CHEMBIOCHEM
卷 14, 期 16, 页码 2127-2135出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201300359
关键词
bacterial resistance; enhanced intracellular survival protein; enzymatic reaction; multi-acetylation; tuberculosis
资金
- National Institutes of Health (NIH) [AI090048]
- Firland Foundation
- Cellular Biotechnology Training Program
- Rackham Merit Fellowship
- American Foundation of Pharmaceutical Education fellowship
A recently discovered cause of tuberculosis resistance to a drug of last resort, the aminoglycoside kanamycin, results from modification of this drug by the enhanced intracellular survival (Eis) protein. Eis is a structurally and functionally unique acetyltransferase with an unusual capability of acetylating aminoglycosides at multiple positions. The extent of this regioversatility and its defining protein features are unclear. Herein, we determined the positions and order of acetylation of five aminoglycosides by NMR spectroscopy. This analysis revealed unprecedented acetylation of the 3-amine of kanamycin, amikacin, and tobramycin, and the -amine of the 4-amino-2-hydroxybutyryl group of amikacin. A crystal structure of Eis in complex with coenzyme A and tobramycin revealed how tobramycin can be accommodated in the Eis active site in two binding modes, consistent with its diacetylation. These studies, describing chemical and structural details of acetylation, will guide future efforts towards designing aminoglycosides and Eis inhibitors to overcome resistance in tuberculosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据